VR
VRTX
Jun 30, 2023
Quarter ended Jun 30, 2023 · FY2023 Q2

Vertex Pharmaceuticals Incorporated stock research

Vertex Pharmaceuticals (VRTX) Free Cash Flow — Quarter Ended Jun 30, 2023

Cash conversion improved sequentially as revenue and operating cash flow rose, driving higher free cash flow and an enhanced margin. Compared to the same quarter last year, revenue was higher but free cash flow margin was lower, as operating cash flow was similar while capital expenditure increased.

Free cash flow takeaway

A quick read on the company's cash generation and what it means for investors.

Cash conversion improved sequentially as revenue and operating cash flow rose, driving higher free cash flow and an enhanced margin. Compared to the same quarter last year, revenue was higher but free cash flow margin was lower, as operating cash flow was similar while capital expenditure increased.

  • Revenue increased, operating cash flow improved, and capital expenditure was moderately higher, resulting in free cash flow growth and a higher margin compared to the prior quarter.
  • Sequentially, revenue, operating cash flow, free cash flow, and margin all improved. Year-over-year, revenue was higher but free cash flow margin was lower, as operating cash flow was similar while capital expenditure was slightly higher.

FCF snapshot

Quarterly and TTM cash-flow metrics with the minimum valuation context.

TTM free cash flow

$3.9B

Trailing twelve-month free cash flow.

Quarter free cash flow

$1.1B

Free cash flow in the selected fiscal quarter.

Operating cash flow

$1.1B

Cash generated by operations before capital spending.

CapEx

$59.6M

Capital spending and related asset purchases.

FCF margin

43.1%

The share of revenue converted into free cash flow.

Cash flow trend

A short quarterly history shows whether FCF is scaling with revenue or only spiking for one period.

PeriodRevenueOperating CFCapExFCFFCF margin
2022-09-30$2.3B$955.5M$54.2M$901.3M38.6%
2022-12-31$2.3B$1.1B$33.6M$1.0B45.4%
2023-03-31$2.4B$899.9M$42.1M$857.8M36.1%
2023-06-30$2.5B$1.1B$59.6M$1.1B43.1%

Cash conversion quality

Checks that separate high-quality free cash flow from accounting noise or working-capital timing.

FCF / net income117.4%Shows whether accounting earnings convert into cash.
CapEx / revenue2.4%Lower capital intensity usually supports FCF margin.
Net cashn/aCash and equivalents minus total debt.

Recent events shaping cash flow

Near-term business events that help explain the free cash flow result.

Supportive

Operating Cash Flow Increase

Operating cash flow improved significantly compared to the prior quarter, outpacing the revenue increase and supporting higher free cash flow.

This contributed to a higher free cash flow margin despite a modest rise in capital expenditure.

What the cash flow says

How to interpret the company's free cash flow beyond the headline number.

Revenue increased, operating cash flow improved, and capital expenditure was moderately higher, resulting in free cash flow growth and a higher margin compared to the prior quarter.

Sequentially, revenue, operating cash flow, free cash flow, and margin all improved. Year-over-year, revenue was higher but free cash flow margin was lower, as operating cash flow was similar while capital expenditure was slightly higher.

Capital expenditure increased relative to both the prior quarter and the year-ago period, warranting attention.

VRTX Free Cash Flow — Quarter Ended Jun 30, 2023